SuspendedNot Applicable

Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation

Israel20 participantsStarted 2007-09

Plain-language summary

The purpose of this study is to determine the safety and efficacy of using WaisFix100i device for Intracapsular Femoral Fracture Fixation.

Who can participate

Age range

50 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Male/Female with Intracapsular femoral fracture type Garden I-II and several III.
. Age 50 to 75.
. Subject able to comprehend and give informed consent for participation in this study.

Exclusion criteria

. Known active infectious disease.
. Terminal diseases
. Patients in high risk and/or acute cardio-vascular disease.
. Known cognitive disorder, psychiatric and/or neurological disease
. Physician objection.
. Age under 50 or above 75.
. Concurrent participation in any other clinical study
. Patients cannot understand or not willing to sign the informed consent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The safety endpoint is measure by paucity incidence of treatment related major complications.

Timeframe: Study duration

Trial details

NCT IDNCT00521716

SponsorOrthoMediTec

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2008-03

View on ClinicalTrials.gov More Hip Fracture trials